BIOPharma-MEA

Biopharma MEA, was founded in 2007, by Sh. Yasser Naghi, and Dr. Mohamed Ramzy. It was created as an affiliate of Cigalah Group, responsible for the marketing and sales promotion for certain niche and biotech pharmaceutical products across the Middle East region. Cigalah Group is a leading Saudi pharmaceutical distributor, representing over 30 pharmaceutical companies in Saudi Arabia, and enjoying long experience in the pharmaceutical industry. Biopharma MEA is focusing its activities on the marketing and sales promotion, collaborating with local distributors in each market for the required logistic activities. Since its Creation, Biopharma MEA had successfully introduced many "New to Market" and "New in Class" products to the Middle East markets. These introductions have been done in full coordination with our partners. Over the last years we have been achieving numerous successes with our partners, putting robust milestones for new therapies in our markets and shaping the future of many existing therapeutic areas.